3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Multiple Myeloma
15
Leukemia, Lymphocytic, Chronic, B-Cell
10
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma, Follicular
7
Lymphoma, Non-Hodgkin
6
Burkitt Lymphoma
6
Lymphoma, Mantle-Cell
5
Lymphoma, B-Cell, Marginal Zone
5
Lymphoma
5
Astrocytoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic Syndromes
3
Lymphoma, T-Cell, Cutaneous
3
Leukemia, Myelomonocytic, Chronic
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Myeloid, Acute
3
Hematologic Diseases
3
Waldenstrom Macroglobulinemia
2
Uveal Melanoma
2
Smoldering Multiple Myeloma
2
Sezary Syndrome
2
Optic Nerve Glioma
2
Oligodendroglioma
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large-Cell, Anaplastic
2
Leukemia, Promyelocytic, Acute
2
Interventions
Cisplatin
4
Platinum
3
Cetuximab
3
1,2-diaminocyclohexaneplatinum II citrate
3
Immunoglobulin G
2
Fluorouracil
2
Docetaxel
2
Disulfides
2
Carboplatin
2
Bevacizumab
2
temsirolimus
1
dl1520
1
dehydroftorafur
1
cediranib
1
atezolizumab
1
adavosertib
1
Specimen Handling
1
Soybean Proteins
1
Sirolimus
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
(225)Ac-DOTA-c(RGDyK)
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NIH
×
Lymphoid Interstitial Pneumonia
×
Lenalidomide
×
Clear all
NCT01254617
2020-03-13
ADCC
National Cancer Institute (NCI)
Phase 1
Completed
24 enrolled